Health Canada
- Status: approved
Triple therapy for 14 days (Triple therapy for 14 days) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.